E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/8/2010 in the Prospect News Bank Loan Daily and Prospect News High Yield Daily.

S&P rates Omega Healthcare notes BB+

Standard & Poor's said it assigned its BB+ rating to Omega Healthcare Investors Inc.'s proposed $200 million senior unsecured notes due Feb. 15, 2020. A recovery rating of 2 was assigned, indicating a recovery of 70% to 90% in the event of default.

The note offering does not affect the company's BB corporate credit rating and positive outlook.

The company said the proceeds will go toward repaying borrowings under its secured credit facility and for other corporate purposes, including purchasing assets under a previously negotiated acquisition agreement with CapitalSource Inc., S&P said.

The company's leverage is expected to remain near 55% of capital with a debt-to-EBITDA ratio remaining below 4.5x after adjusting for the proposed notes and the April 1 acquisitions, the agency said.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.